Advice You - Business

How much time every week do you spend in meetings? Do you feel every such meeting gives you better pay off than the equivalent time and energy spent elsewhere?

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

While meetings can easily get unproductive and do nothing more than drain your energy, it does not have to be that way. Here are some practical tips that can

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

drastically increase your effectiveness in dealing with meetings.

Before attending or initiating any meeting, ask yourself “What are the intended outcomes

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

from this meeting and/or from my attendance?” Write down your answers. Addressing this question first and identifying clear answers is absolutely critical

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

for anything else you do in connection to that event.

The second important question is “What is the best tool to reach those outcomes?” Remember that a

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

meeting is just one of the tools of interpersonal communication. Like any tool, it serves well for certain business situations, but may be ineffective for man

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

y others. Would it be more effective to achieve any of the objectives some other way? For example, you could make a phone call, distribute a memo, or just make

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

some decisions on your own.

It does not matter how well run is the meeting if that meeting does not need to be conducted in the first place. Similarly, bef

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ore attending a meeting, check if you could obtain or share the same information or insights better and more efficiently some other way.

The next critical que

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

stion for an effective meeting is “Who are the right people to be at the meeting?” Are there any people (including yourself) who are not expected to get

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

any noticeable benefits or to give any relevant help in this particular meeting? No need to waste their time. On the other hand, could you invite an additional

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

person with some helpful expertise, insights, or first hand facts relevant for the meeting purposes?

The next step is to prepare and distribute an agenda. Th

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

e agenda should communicate briefly but clearly the purpose of the meeting, the schedule of the presentations by the participants, and the key points for discu

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ssion, all with specific time frames. It is desirable to put the more important presentations and points first.

For meetings where you are not the organizer,

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

still pay attention to the agenda and make sure you have it in advance. Having a clear agenda that is properly communicated to everyone before the meeting se

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

rves a number of purposes, both before and during the meeting. Before the meeting, the agenda allows everyone to prepare. Even when no practical action steps a

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

re required or done, the agenda prepares everyone for more effective work during the meeting. In the meeting room, the agenda sets priorities and time frames.

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

It is a necessary tool for keeping the meeting productive and focused.

Finally, the guidelines above are essential for practically any productive meeting. Yet

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

, depending on the number and diversity of the attendees, the standards of your organization, and your personal standards of excellence, there are some finer d

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

etails you may want to keep in mind. From choosing the right time, location, and seating, to recognizing and managing interpersonal dynamics during the meeting

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/23386/adviceyou-Tired-of-Unproductive-Meetings.html">Tired of Unproductive Meetings?</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/23386/adviceyou-Tired-of-Unproductive-Meetings.html]Tired of Unproductive Meetings?[/url]

The recent Sarbanes-Oxley Act requires far more detailed disclosure of your public company's filings with SEC then ever before. In this article, you'll discover how to properly protect and meet all of the Sarbanes-Oxley Act requirements for your company's valuable Intellectual Property assets.

Should you use real skip tracers or just databases? This has crossed the mind of more than one collection manager. There are pros and cons to each side.

Good customer service is more than just being quick and having a good product. It's also about learning what your customers like and don't like and being ready BEFORE the inevitable happens. This is an example of how to be ready!

Tags

Links

Advice You - Tired of Unproductive Meetings?

Related Articles: